Medidata VP of Product Strategy Honored Among PharmaVOICE 100 Most Inspiring People
August 01 2014 - 9:54AM
Business Wire
Michelle Marlborough Recognized for
Innovation in Transforming Clinical Trials with Cloud Technology
and Analytics
Medidata (NASDAQ:MDSO), the leading global provider of
cloud-based solutions for clinical research in life sciences, is
pleased to announce that Michelle Marlborough, the company’s vice
president of product strategy, has been named by
PharmaVOICE Magazine as one of the 100 most inspiring people
in the life sciences industry.
Recently honored as a 2014 Rising Star by the Healthcare
Businesswomen’s Association (HBA), Marlborough has been at the
forefront of transforming clinical trials with innovative
technology and analytics. She leads the Medidata team responsible
for designing a platform of cloud-based solutions that is
modernizing drug development, helping life sciences companies bring
needed therapies to patients faster and with lower cost and
risk.
"This recognition is a terrific reaffirmation of what we at
Medidata already knew: Michelle has been instrumental to our
success, and she is constantly pushing our industry to modernize
drug development through the use of innovative technologies," said
Glen de Vries, Medidata’s president. "Michelle's
vision unifies the needs of our clients with data-driven
analytics and the patient's voice. We are thrilled that
PharmaVOICE agrees her contribution is worthy of praise."
With this honor, Marlborough becomes the ninth Medidata
executive to be named to the PharmaVOICE 100, an annual list of
individuals recognized for translating industry issues into
opportunities and pioneering new paths to success for life
sciences. Distinguished honorees represent a broad cross section of
the industry, including pharmaceutical, biopharmaceutical,
biotechnology, contract research, clinical trial, research and
development, patient education, patient recruitment, advertising,
marketing, technology and many other sectors.
"Michelle is an industry thought leader and a passionate
proponent of the role technology can play in improving clinical
research,” said Taren Grom, editor of PharmaVOICE Magazine. “She
truly understands the value technology brings to drug
development and its potential to make clinical trials run better,
smarter and safer. We are proud to include Michelle on this year's
PharmaVOICE 100 list of the most inspiring leaders in the life
sciences industry."
Connect with Medidata:
- Read our blog, Geeks Talk Clinical
- Tweet this: .@Medidata VP Michelle
Marlborough (@ProtocolQueen) named one of #PharmaVOICE100 most
inspiring people. @PharmaVOICE http://bit.ly/1uM6Lr3
- Follow us on Twitter: @Medidata
- Find us on LinkedIn
About PharmaVOICE
PharmaVOICE is expressly written and designed to deliver
the views, opinions, and insights of executives who are shaping the
direction of the dynamic life sciences industry. PharmaVOICE
reaches more than 29,000 subscribers every month in print and more
than 100,000 readers through its online version, which contains
original exclusive bonus content. PharmaVOICE’s unique
horizontal editorial approach cuts industry silos, providing a
holistic overview of the life sciences industry, addressing a range
of topics from molecule through market. By engaging compelling
personalities from diverse industry
sectors, PharmaVOICE provides multiple perspectives on
business challenges, trends, and topics. Editorial content sparks
dialog, initiates debate, and opens the lines of communication to
facilitate and improve business-to-business
relationships. PharmaVOICE's multiple-perspective and in-depth
original forums, feature articles, topics, and departments are
audience-driven. PharmaVOICE provides executives with
useful peer-to-peer insights on a broad range of life sciences
business practices and topics.
About Medidata Solutions
Medidata is the leading global provider of cloud-based solutions
for clinical research in life sciences, transforming clinical
development through its advanced applications and intelligent data
analytics. The Medidata Clinical Cloud™ brings new levels of
productivity and quality to the clinical testing of promising
medical treatments, from study design and planning through
execution, management and reporting. We are committed to advancing
the competitive and scientific goals of global clients, which
include over 90% of the top 25 global pharmaceutical companies;
innovative biotech, diagnostic and device firms; leading academic
medical centers; and contract research organizations.
Media:Medidata SolutionsGail Janowitz,
212-918-1792gjanowitz@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024